Every Form 4 that Rhinebeck Bancorp Inc (RBKB) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow RBKB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RBKB filings page.
Rhinebeck Bancorp, Inc. executive Michael Vitale, EVP and Head of Commercial Banking, purchased 4,834 shares of common stock on August 6, 2026 at $12.35 per share. Following this open-market or private transaction, he directly holds 22,414 shares, including restricted stock vesting 33 1/3% annually starting April 21, 2027.
Rhinebeck Bancorp, Inc. director Suzanne Loughlin purchased a total of 12,500 shares of common stock on July 22, 2026, in open market or private transactions at prices of $11.92 and $11.93 per share. Footnotes state these shares are restricted stock vesting 33 1/3% annually starting May 26, 2027. She also holds fully vested stock options exercisable for 22,875 shares of common stock at an exercise price of $4.70 per share, expiring August 25, 2030.
Rhinebeck Bancorp, Inc. executive Michael Vitale, EVP and Head of Commercial Banking, purchased 5,000 shares of common stock on July 22, 2026 at $11.94 per share in a direct open-market or private transaction, bringing his direct holdings to 17,580 shares, including restricted stock vesting 33 1/3% annually starting April 21, 2027.
Rhinebeck Bancorp, Inc. director Nancy Koskey Patzwahl reported purchasing 25,000 shares of common stock on July 22, 2026 at $11.94 per share in a transaction classified as an open-market or private purchase, increasing her direct holdings to 27,270 shares of restricted stock that vest 33 1/3% annually beginning May 26, 2027.
Rhinebeck Bancorp, Inc. President & CEO Matthew James Smith purchased a total of 12,425 shares of common stock on July 22, 2026, in two direct transactions: 2,300 shares at $11.995 per share and 10,125 shares at $12.00 per share.
The acquired shares are described as restricted stock that vest 33 1/3% per year commencing on May 26, 2027. Smith also reports indirect ownership of 479 common shares held through a 401(k), reflecting plan transactions not required to be reported under Section 16.
Rhinebeck Bancorp, Inc. director William C. Irwin reported a grant/award acquisition of 10,000 shares of common stock on 2026-07-21 at 10.0000 per share. These shares are restricted stock that vest 33 1/3% per year beginning May 26, 2027. Following the award, he holds 50,937 common shares directly. He also holds fully vested stock options exercisable at 4.7000 per share for 15,250 underlying common shares, expiring on August 25, 2030. Share and option figures reflect a 1.3978 to 1.00 stock exchange ratio related to the company’s mutual to stock conversion.
Rhinebeck Bancorp, Inc. director Freddimir Garcia received a grant of 500 shares of restricted common stock at $10.00 per share on July 21, 2026. These restricted shares vest 33 1/3% per year starting May 26, 2027, bringing his direct common stock holdings to 7,206 shares.
Garcia also reports fully vested stock options covering 22,875 shares of common stock with an exercise price of $4.70 per share, expiring on August 25, 2030. Share and option figures reflect a 1.3978-to-1.00 exchange ratio from the company’s mutual-to-stock conversion.
Rhinebeck Bancorp, Inc. director Patzwahl Nancy Koskey reports direct ownership of 2,270 shares of common stock. This amount reflects a 1.3978-to-1.00 stock exchange ratio used in the company’s mutual to stock conversion, and footnotes describe restricted shares vesting 33 1/3% annually starting May 26, 2027.
Rhinebeck Bancorp, Inc. director Sharon McGinnis reports direct ownership of 2,270 shares of common stock. A footnote states this amount reflects a 1.3978-to-1 stock exchange ratio tied to the company’s mutual-to-stock conversion, and that these restricted shares vest in equal 33 1/3% annual installments beginning May 26, 2027.
Rhinebeck Bancorp, Inc. director Shannon Martin LaFrance received a grant of 2,700 shares of Common Stock as restricted stock at $10.00 per share. These shares vest 33 1/3% per year starting on May 26, 2027. After this award, she directly holds 35,341 common shares. She also holds fully vested stock options for 22,875 shares of common stock at an exercise price of $4.70 per share, expiring on August 25, 2030. Share amounts and option terms reflect a 1.3978-to-1.00 stock exchange ratio related to the company’s mutual to stock conversion.
Rhinebeck Bancorp, Inc. director Steven E. Howell reported his current equity positions. He holds 22875 stock options on common stock, with a fully vested status, an exercise price of $4.7000 and expiration on 2030-08-25. He also holds 9259 common shares directly and 6989 indirectly through a 401(k) plan. The share counts and option exercise price reflect a 1.3978 to 1.00 stock exchange ratio from the mutual-to-stock conversion, and shares of restricted stock vest at 33 1/3% per year beginning May 26, 2027.
Rhinebeck Bancorp, Inc. director Suzanne Loughlin reports direct ownership of 34,328 shares of Common Stock and fully vested stock options covering 22,875 shares at an exercise price of $4.7000 per share, expiring on August 25, 2030. These amounts reflect a 1.3978-to-1.00 stock exchange ratio from the company's mutual to stock conversion, and certain restricted shares vest 33 1/3% per year beginning May 26, 2027.
Rhinebeck Bancorp, Inc. executive Michael Vitale, EVP and Head of Commercial Banking, reported direct ownership of 12,580 shares of common stock. This amount reflects a 1.3978-to-1 stock exchange ratio from the company’s mutual to stock conversion and includes restricted shares vesting 33 1/3% annually starting April 21, 2027.
Rhinebeck Bancorp, Inc. director and President & CEO Matthew James Smith reported his beneficial ownership of Common Stock. He holds 23,826 shares directly and 479 shares indirectly through a 401(k) plan, amounts that reflect a 1.3978-to-1.00 stock exchange ratio in connection with the company’s mutual to stock conversion. Footnotes state that shares of restricted stock vest at 33 1/3% per year beginning May 26, 2027, and that the 401(k) position reflects transactions not required to be reported under Section 16.
Rhinebeck Bancorp, Inc. executive Kevin M. Nihill, CFO and Treasurer, reports direct ownership of 33,121 shares of common stock as of 2026-07-21. The position reflects a 1.3978-to-1.00 stock exchange ratio tied to the company’s mutual to stock conversion and includes restricted shares vesting 33 1/3% per year from grants beginning July 9, 2025 and May 26, 2027.
No share purchases or sales are shown; the report details his post-conversion and restricted stock holdings.
Rhinebeck Bancorp, Inc. reported that SVP and Chief Accounting Officer Phillip Lekanides acquired 500 shares of restricted common stock at $10.0000 per share and 1,368 shares through a 401(k) on July 21, 2026. Following these awards he holds 8,487 shares directly, 6,626 via a 401(k), 2,588 via an ESOP, and fully vested options on 2,096 shares at a $4.7000 exercise price expiring August 25, 2030. The restricted shares vest 33 1/3% annually starting May 26, 2027.
Rhinebeck Bancorp, Inc. Chief Credit & Risk Officer James T. McCardle III received a grant of 2,500 shares of Common Stock at $10.00 on July 21, 2026, allocated to his 401(k). After this, he holds 16,279 shares via the 401(k), 16,440 shares directly, 5,178 shares via an ESOP, and fully vested options on 39,138 shares at a $4.70 exercise price expiring August 25, 2030. Certain amounts reflect a 1.3978-to-1.00 stock exchange ratio from a mutual‑to‑stock conversion, and some restricted stock vests 33 1/3% annually beginning May 26, 2027.
Rhinebeck Bancorp director Christopher W. Chestney received a grant of 10,000 shares of Common Stock on July 21, 2026 at a reported $10.00 per share. After this award, he directly holds 40,940 common shares, including restricted stock that vests 33 1/3% per year beginning May 26, 2027. He also has fully vested stock options covering 22,875 shares at a $4.70 exercise price expiring August 25, 2030, plus indirect holdings of 1,397 common shares reported as held by his spouse, 1,397 by his son, and 1,397 by his daughter.
Rhinebeck Bancorp, Inc. reports that Chief Operating Officer Jamie J. Bloom received a grant of 1000.0000 shares of Common Stock at $10.0000 per share into a 401(k), increasing that indirect holding to 2970.0000 shares. Bloom now holds 14707.0000 direct shares, indirect ESOP holdings of 5589.0000 shares, and fully vested stock options on 39138.0000 underlying shares at a $4.7000 exercise price, which reflects a 1.3978-to-1.00 exchange ratio from the mutual-to-stock conversion. Restricted stock is scheduled to vest 33 1/3% per year starting May 26, 2027.
Rhinebeck Bancorp, Inc. director Donald E. Beeler Jr. reported his equity positions. He directly holds 4,488 common shares, including restricted stock vesting 33 1/3% annually beginning May 26, 2027. He also holds fully vested stock options covering 22,875 shares at a $4.70 exercise price, expiring August 25, 2030, all adjusted for a 1.3978-to-1.00 exchange ratio from the company’s mutual to stock conversion.
Rhinebeck Bancorp, Inc. officer Kevin M. Nihill, CFO and Treasurer, reported a Form 4 transaction involving Common Stock. On July 9, 2026, he had a tax-withholding disposition of 1,468 shares at $17.08 per share, characterized as payment of tax liability by delivering securities rather than an open-market sale. Following this event, he directly holds 23,696 shares, which include restricted stock that vests in equal annual installments of 33 1/3% beginning on July 9, 2025 and May 26, 2027.
Rhinebeck Bancorp, Inc. director Steven E. Howell reported a compensation-related stock award rather than an open-market trade. He received 1,624 shares of common stock at no cost, increasing his directly held common stock to 6,624 shares. These shares are restricted and will vest in three equal annual installments beginning on May 26, 2027. Howell also reports indirect ownership of 5,000 common shares through a 401(k) plan and holds fully vested stock options covering 16,365 shares of common stock at an exercise price of $6.57 per share, expiring in 2030.
Rhinebeck Bancorp, Inc. Chief Credit & Risk Officer James T. McCardle III received a grant of 8,182 shares of Common Stock at no cost as a stock award, increasing his direct holdings to 11,762 shares. A footnote states these restricted shares vest at a rate of 33 1/3% per year commencing on May 26, 2027. The filing also reports indirect holdings of 3,705 shares through an ESOP and 9,858 shares through a 401(k), and shows fully vested stock options covering 28,000 shares of Common Stock at an exercise price of $6.57 per share expiring August 25, 2030.
Rhinebeck Bancorp, Inc. Chief Operating Officer Jamie J. Bloom reported a compensation-related stock grant. Bloom received 10,487 shares of Common Stock at $0.00 per share as a grant or award, bringing direct Common Stock holdings to 10,522 shares after the transaction. A footnote states these are restricted shares that vest in equal installments of 33 1/3% per year starting on May 26, 2027. The filing also shows indirect holdings of 3,999 Common shares through an ESOP, 1,410 Common shares through a 401(k), and stock options on 28,000 underlying Common shares that are fully vested with a $6.57 exercise price and an expiration date of August 25, 2030.
Rhinebeck Bancorp, Inc. director Nancy Koskey Patzwahl reported a compensation-related stock grant. She acquired 1,624 shares of common stock as an award at a stated price of $0.00 per share, bringing her directly held position to 1,624 shares.
The award is in the form of restricted stock that vests over time. According to the disclosure, these shares vest at a rate of 33 1/3% per year, commencing on May 26, 2027, meaning the grant becomes fully vested over three years starting from that date.
Rhinebeck Bancorp director Sharon McGinnis reported an acquisition of 1,624 shares of Common Stock through a grant or award with a stated price of $0.00 per share. These are restricted shares that vest in thirds, with 33 1/3% vesting each year starting on May 26, 2027. After this award, McGinnis directly holds 1,624 shares, reflecting a routine compensation-related equity grant rather than an open-market purchase.
Rhinebeck Bancorp director Suzanne Loughlin reported a routine equity compensation grant and her existing option holdings. She received 1,624 shares of Common Stock as a grant at $0.00 per share, increasing her direct holdings to 24,559 shares of Common Stock.
The granted shares are restricted stock that will vest in three equal annual installments of 33 1/3% starting on May 26, 2027. She also holds fully vested stock options covering 16,365 shares of Common Stock at an exercise price of $6.57 per share, expiring on August 25, 2030.
Rhinebeck Bancorp, Inc. director Shannon Martin LaFrance reported an equity compensation award on common stock. LaFrance received 1,624 shares of restricted common stock at a stated price of $0.00 per share, classified as a grant or award rather than an open‑market purchase. These restricted shares vest in equal installments of 33 1/3% per year starting on May 26, 2027. Following this award, LaFrance directly holds 23,352 shares of common stock. The filing also shows fully vested stock options covering 16,365 underlying common shares with an exercise price of $6.57 per share that expire on August 25, 2030, indicating an additional derivative equity position.
Rhinebeck Bancorp, Inc. senior vice president and chief accounting officer Phillip Lekanides received a grant of 3,410 shares of common stock at no cost as a restricted stock award. These shares vest at a rate of 33 1/3% per year starting on May 26, 2027.
After this award, Lekanides directly holds 5,715 common shares. He also has indirect holdings of 1,852 shares through an ESOP and 3,744 shares through a 401(k). In addition, he holds fully vested stock options covering 1,500 shares of common stock at an exercise price of $6.57 per share, expiring on August 25, 2030. Other entries reflect holdings not required to be reported as Section 16 transactions.
Rhinebeck Bancorp director Freddimir Garcia reported a stock-based compensation grant. He received 1,624 shares of restricted Common Stock at no cash cost, increasing his direct common share holdings to 4,798.
The restricted shares vest in three equal installments of 33 1/3% per year starting on May 26, 2027. Garcia also holds fully vested stock options covering 16,365 shares of Common Stock with an exercise price of $6.57 per share, expiring on August 25, 2030.
Rhinebeck Bancorp, Inc. director Christopher W. Chestney reported an award of 1,624 shares of Common Stock as a grant or other acquisition at $0.00 per share, bringing his directly held common shares to 22,135.
The granted shares are restricted stock that vest at a rate of 33 1/3% per year starting on May 26, 2027. He also holds fully vested stock options covering 16,365 shares of Common Stock at an exercise price of $6.57 per share, expiring on August 25, 2030. In addition, Form 4 reflects indirect holdings of 1,000 shares each held by his daughter, son, and spouse.
Rhinebeck Bancorp, Inc. President & CEO Matthew James Smith reported an equity compensation grant and updated holdings. He received 17,046 shares of common stock as a restricted stock award at $0.0000 per share, held directly after the grant. According to the filing, these restricted shares vest at a rate of 33 1/3% per year starting on May 26, 2027, meaning the award will vest in three equal annual installments. The filing also shows 245 common shares held indirectly through a 401(k) plan. There were no open-market purchases or sales; the main activity is a compensation-related acquisition.
Nihill Kevin M reported acquisition or exercise transactions in this Form 4 filing.
Rhinebeck Bancorp, Inc. executive Kevin M. Nihill, CFO and Treasurer, received a grant of 9,632 shares of restricted common stock on May 26, 2026 at no cash cost. After this award, he directly holds 25,164 shares. The new restricted stock vests in three equal annual installments starting May 26, 2027, and his total holdings include other restricted shares that begin vesting in thirds from July 9, 2025.
Rhinebeck Bancorp, Inc. director Donald E. Beeler Jr. reported a grant of 1,624 shares of Common Stock at no cost, increasing his direct holdings to 3,211 shares of common stock. The shares are restricted stock that vest in equal installments of 33 1/3% per year starting on May 26, 2027, meaning they become fully his over three years.
He also reports a continuing position in stock options linked to 16,365 shares of Common Stock with an exercise price of $6.57 per share, expiring on August 25, 2030. These stock options are fully vested, so they are currently exercisable under the plan’s terms.
Rhinebeck Bancorp, Inc. director William C. Irwin reported a stock award and his current equity holdings. He received a grant of 1,624 shares of Common Stock as a compensation award, increasing his direct holdings to 29,287 shares. The granted shares are restricted stock that vest in three equal annual installments of 33 1/3% per year starting on May 26, 2027. Irwin also holds fully vested stock options exercisable for 10,910 shares of Common Stock at an exercise price of $6.57 per share, expiring on August 25, 2030.
Rhinebeck Bancorp, Inc. reported that officer Philip J. Bronzi executed an open-market sale of common stock. He sold 4,162 shares of common stock at $15.915 per share, reducing his directly held common stock to 0 shares after the transaction.
The filing also shows indirect holdings that remain unchanged, including 3,548 shares of common stock held through an ESOP and 10,980 shares held through a 401(k) plan, both reported as indirect ownership.
Vitale Michael reported acquisition or exercise transactions in this Form 4 filing.
Rhinebeck Bancorp, Inc. reported that Executive Vice President and Head of Commercial Banking Michael Vitale received a grant of 9,000 shares of common stock as a stock award. These shares are restricted stock and will vest in stages rather than all at once.
The restricted stock vests at a rate of 33 1/3% per year, beginning on April 21, 2027. After this grant, Vitale holds 9,000 common shares directly, reflecting a routine compensation-related equity award rather than an open-market purchase or sale.
Rhinebeck Bancorp, Inc. senior vice president and chief accounting officer Phillip Lekanides exercised stock options to acquire 500 shares of common stock at $6.57 per share. After the exercise, he holds 2,305 shares directly, along with 1,852 shares through an ESOP and 3,733 shares through a 401(k) plan. The stock options are fully vested, and 1,500 options remain outstanding following this transaction.
Rhinebeck Bancorp, Inc. executive Philip J. Bronzi reported routine equity transactions involving company common stock. On April 28, 2026, he exercised stock options to acquire 7,000 shares of common stock at $6.57 per share, converting a derivative award into direct share ownership.
To cover tax obligations, 2,838 shares of common stock were used in a tax-withholding disposition at $16.20 per share. After these transactions, Bronzi directly held 4,162 shares of common stock and had additional indirect holdings of 3,548 shares through an ESOP and 10,980 shares through a 401(k) plan. The filing notes that some reflected transactions are not required to be reported under Section 16, underscoring their routine nature.
Rhinebeck Bancorp (RBKB) reported an insider transaction by its CFO and Treasurer. On 11/06/2025, the officer purchased 1,000 shares of common stock at $9.67 per share. Following this trade, the officer beneficially owns 15,532 shares, held directly.
The reported total includes restricted stock that vests at a rate of 33 1/3% per year commencing on July 9, 2025.